Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-07-08

FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Aurobindo Pharma Limited, updating the approved generic product under its ANDA. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN MESYLATE)